Since the EMT process in CCA can be regulated by several signaling pathways, the key molecules reported as underlying pathways of EMT promotion in CCA, i.e., Akt, ERK, and STAT3, were then investigated after the treatment of liraglutide. This evidence concerns the gene AKT1 and cholangiocarcinoma.